These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1818 related items for PubMed ID: 26384851
21. A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection. Wajswol E, Winoker JS, Anastos H, Falagario U, Okhawere K, Martini A, Treacy PJ, Voutsinas N, Knauer CJ, Sfakianos JP, Lewis SC, Taouli BA, Rastinehad AR. BJU Int; 2020 Apr; 125(4):531-540. PubMed ID: 31762182 [Abstract] [Full Text] [Related]
22. Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostate. Maxeiner A, Kittner B, Blobel C, Wiemer L, Hofbauer SL, Fischer T, Asbach P, Haas M, Penzkofer T, Fuller F, Miller K, Cash H. BJU Int; 2018 Aug; 122(2):211-218. PubMed ID: 29569320 [Abstract] [Full Text] [Related]
23. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy. Mannaerts CK, Gayet M, Verbeek JF, Engelbrecht MRW, Savci-Heijink CD, Jager GJ, Gielens MPM, van der Linden H, Beerlage HP, de Reijke TM, Wijkstra H, Roobol MJ. Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233 [Abstract] [Full Text] [Related]
24. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer. Alberts AR, Roobol MJ, Drost FH, van Leenders GJ, Bokhorst LP, Bangma CH, Schoots IG. BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899 [Abstract] [Full Text] [Related]
25. [Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer]. Distler F, Radtke JP, Kesch C, Roethke M, Schlemmer HP, Roth W, Hohenfellner M, Hadaschik B. Urologe A; 2016 Feb; 55(2):146-55. PubMed ID: 26556268 [Abstract] [Full Text] [Related]
27. Multiparametric MRI in detection and staging of prostate cancer. Boesen L. Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [Abstract] [Full Text] [Related]
35. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy. Borkowetz A, Platzek I, Toma M, Renner T, Herout R, Baunacke M, Laniado M, Baretton G, Froehner M, Zastrow S, Wirth M. BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133 [Abstract] [Full Text] [Related]
36. Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate: an original technique with a good cancer detection rate. Wang L, Wang X, Zhao W, Zhao Z, Li Z, Fei S, Zhu H, Ji X, Yang B, Li N, Na Y. BMC Urol; 2019 Nov 04; 19(1):107. PubMed ID: 31684917 [Abstract] [Full Text] [Related]
38. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Pokorny MR, de Rooij M, Duncan E, Schröder FH, Parkinson R, Barentsz JO, Thompson LC. Eur Urol; 2014 Jul 04; 66(1):22-9. PubMed ID: 24666839 [Abstract] [Full Text] [Related]
39. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes. Meng X, Rosenkrantz AB, Mendhiratta N, Fenstermaker M, Huang R, Wysock JS, Bjurlin MA, Marshall S, Deng FM, Zhou M, Melamed J, Huang WC, Lepor H, Taneja SS. Eur Urol; 2016 Mar 04; 69(3):512-7. PubMed ID: 26112001 [Abstract] [Full Text] [Related]